Drug Profile
Research programme: HIV/AIDS vaccine - Biological Mimetics
Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Biological Mimetics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in HIV-infections(Prevention) in USA (Parenteral)
- 01 Jul 2016 Early research in HIV infections (Prevention) in USA (Parenteral)